EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Viscerotropic Leishmaniasis in Iran: Current Insights and Future Directions: A Narrative Review

Reza Shafiei, Mohammad Amin Ghatee, Ahmad Gholami, Bahador Sarkari

Iranian Journal of Parasitology · 02.06.2026

DOI: 10.18502/ijpa.v21i1.21628 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Iranian Journal of Parasitology, online erschienen am 02.06.2026. Verfasst von Reza Shafiei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, North Khorasan University of Medical Sciences, Bojnurd, Iran. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This narrative review synthesizes the current evidence on the geographic distribution, diagnostic approaches, and clinical and epidemiological characteristics of Viscerotropic leishmaniasis (VTL) in both human and animal hosts in Iran. A comprehensive search of electronic databases (PubMed, Web of Science, etc.) was conducted for articles (1997 to 2025) reporting VTL in Iran with PCR-based species confirmation. Twenty-three studies met the inclusion criteria and were analyzed. The findings indicate that VTL in Iran is predominantly caused by Leishmania tropica, with notable cases attributed to L. major. A key finding is the frequent reporting of treatment failure with pentavalent antimonials in these VTL cases. Conversely, L. infantum, the typical agent of visceral leishmaniasis (VL), has also been implicated in CL across various regions, suggesting its potential role in dermotropic leishmaniasis (DL) in humans. Rare cases of L. tropica-induced VTL in dogs highlight a potential zoonotic dimension. Reported treatment failure with first-line antimonials in several VTL cases caused by these species, highlighting a critical therapeutic challenge. VTL, primarily caused by L. tropica, represents an emerging public health concern in Iran with distinct epidemiological and therapeutic implications. The reviewed evidence underscores an urgent need for rapid diagnostic tools to differentiate VTL from classic VL and to guide species-specific treatment, as standard antimonial therapy often fails. A multidisciplinary approach integrating enhanced surveillance, targeted research, and revised clinical guidelines is essential to mitigate the burden of this neglected disease.

Schlagwörter

Stichwörter der Autor:innen

IranLeishmania tropicaLeishmaniasisNarrative reviewViscerotropic

Autor:innen und Institutionen

  • Student Research Committee, North Khorasan University of Medical Sciences, Bojnurd, Iran.
  • Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Department of Pharmaceutical Nanotechnology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Basic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Zitieren

APA

Shafiei, R., Amin Ghatee, M., Gholami, A., & Sarkari, B. (2026). Viscerotropic Leishmaniasis in Iran: Current Insights and Future Directions: A Narrative Review. Iranian Journal of Parasitology. https://doi.org/10.18502/ijpa.v21i1.21628

Vancouver

Shafiei R, Amin Ghatee M, Gholami A, Sarkari B. Viscerotropic Leishmaniasis in Iran: Current Insights and Future Directions: A Narrative Review. Iranian Journal of Parasitology. 2026. doi:10.18502/ijpa.v21i1.21628

BibTeX
@article{Shafiei2026,
  author = {Shafiei, Reza and Amin Ghatee, Mohammad and Gholami, Ahmad and Sarkari, Bahador},
  title = {Viscerotropic Leishmaniasis in Iran: Current Insights and Future Directions: A Narrative Review},
  journal = {Iranian Journal of Parasitology},
  year = {2026},
  doi = {10.18502/ijpa.v21i1.21628}
}
Kostenlos starten →